3rd RSC / SCI / New Therapeutics for Global Health
Event
3rd RSC / SCI / SEQT New Therapeutics for Global Health
Dates
Wednesday 19th – Friday 21st June 2024 – A date for your Diary!
Place
GlaxoSmithKline, Tres Cantos, Madrid
Important links and downloads
Twitter hashtag – #NTGH24
First announcement poster – TBC
Synopsis
Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (eg dengue, West Nile), kinetoplastids (causative agents of Chagas disease, leishmaniasis, etc) and gut pathogens (worms, bacteria, parasites), remain a cause of high mortality across the globe. Fortunately, an ever-improving understanding of the complex life-cycles of these disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.
This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts from industry and academia, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst also showcasing the opportunity for creativity and innovation
Registration
Registration will be open soon. Please keep checking back for updates!
Registration fees:
TBC
Want to become a member?
To join the RSC in order to qualify for discounted registration fees at all RSC, please follow this RSC link.
Exhibition/Sponsorship Opportunities
Bookings will be open soon. Please keep checking back for updates!
Programme
Coming soon, please keep checking back for updates!
Organising Committee
Carlos Alemparte, GlaxoSmithKline
Dave Alker, Independent Consultant
Giancarlo Biagini, Liverpool School of Tropical Medicine
Felix Calderon, GlaxoSmithKline (chair)
Martin Lowe, Exscientia
Maria Marco-Martin, GlaxoSmithKline
Jaysheree Mistry, Independent Consultant
Andrew Stachulski, University of Liverpool
Mary Wheldon, University of Dundee (treasurer)
Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333
E-mail